Peripheral Pulmonary Nodules
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: 18 years and above, and 75 years and below, gender not restricted; 2. Chest CT shows peripheral lung lesions and a suspected diagnosis of peripheral lung cancer, requiring biopsy; 3. Chest CT of the patient indicates that the lesion to be biopsied is located in the bronchus below the segment; 4. The patient voluntarily agrees to undergo bronchoscopy and meets the requirements for bronchoscopy; 5. The patient can understand the purpose of the trial, has good compliance with the received examination and follow-up, voluntarily participates in this research project, and signs the informed consent form. 6. The maximum diameter of the lesion to be biopsied is >= 1 cm.
Exclusion criteria
Exclusion criteria: 1. There are contraindications for bronchoscopy, including: active massive hemoptysis; recent myocardial infarction or unstable angina pectoris attack; severe cardiac or pulmonary dysfunction; severe hypertension and arrhythmia; uncorrectable bleeding tendency or severe coagulation disorder (such as platelet count < 60×10^9/L), uremia, severe pulmonary hypertension, severe superior vena cava syndrome; intracranial hypertension; acute cerebrovascular event; aortic dissection or aortic aneurysm; multiple pulmonary bullae; extreme general debilitation; 2. Women who are breastfeeding or pregnant, or those who are planning to conceive; 3. Patients with electromagnetic active implant devices in their bodies; 4. Patients who are allergic to anesthetics; or have a history of multiple severe allergic reactions, or a history of hereditary anaphylaxis; 5. Other situations that the investigator deems unsuitable for participation in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic yield; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of complications; | — |
Countries
China
Contacts
Beijing Chao-yang Hospital, Capital Medical University